These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15611226)

  • 1. Activation of CD40 in cervical carcinoma cells facilitates CTL responses and augments chemotherapy-induced apoptosis.
    Hill SC; Youde SJ; Man S; Teale GR; Baxendale AJ; Hislop A; Davies CC; Luesley DM; Blom AM; Rickinson AB; Young LS; Eliopoulos AG
    J Immunol; 2005 Jan; 174(1):41-50. PubMed ID: 15611226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion.
    Gallagher NJ; Eliopoulos AG; Agathangelo A; Oates J; Crocker J; Young LS
    Mol Pathol; 2002 Apr; 55(2):110-20. PubMed ID: 11950960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40/CD40L expression and its prognostic value in cervical cancer.
    Grazia GA; Bastos DR; Villa LL
    Braz J Med Biol Res; 2023; 56():e13047. PubMed ID: 37970926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of phosphatidylinositol 3-kinase- and ERK MAPK-regulated protein synthesis reveals the pro-apoptotic properties of CD40 ligation in carcinoma cells.
    Davies CC; Mason J; Wakelam MJ; Young LS; Eliopoulos AG
    J Biol Chem; 2004 Jan; 279(2):1010-9. PubMed ID: 14581487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.
    Evans M; Borysiewicz LK; Evans AS; Rowe M; Jones M; Gileadi U; Cerundolo V; Man S
    J Immunol; 2001 Nov; 167(9):5420-8. PubMed ID: 11673561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 is overexpressed by HPV16/18-E6 positive cervical carcinoma and correlated with clinical parameters and vascular density.
    Huang Q; Qu QX; Xie F; Zhang T; Hu JM; Chen YG; Zhang XG
    Cancer Epidemiol; 2011 Aug; 35(4):388-92. PubMed ID: 21251894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions.
    Bontkes HJ; de Gruijl TD; Walboomers JM; van den Muysenberg AJ; Gunther AW; Scheper RJ; Meijer CJ; Kummer JA
    Br J Cancer; 1997; 76(10):1353-60. PubMed ID: 9374383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engagement of CD40 antigen with soluble CD40 ligand up-regulates peptide transporter expression and restores endogenous processing function in Burkitt's lymphoma cells.
    Khanna R; Cooper L; Kienzle N; Moss DJ; Burrows SR; Khanna KK
    J Immunol; 1997 Dec; 159(12):5782-5. PubMed ID: 9550373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.
    Travert M; Ame-Thomas P; Pangault C; Morizot A; Micheau O; Semana G; Lamy T; Fest T; Tarte K; Guillaudeux T
    J Immunol; 2008 Jul; 181(2):1001-11. PubMed ID: 18606651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of CD40 on immunogenic human malignant melanomas augments their cytotoxic T lymphocyte-mediated lysis and induces apoptosis.
    von Leoprechting A; van der Bruggen P; Pahl HL; Aruffo A; Simon JC
    Cancer Res; 1999 Mar; 59(6):1287-94. PubMed ID: 10096561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 induces antigen transporter and immunoproteasome gene expression in carcinomas via the coordinated action of NF-kappaB and of NF-kappaB-mediated de novo synthesis of IRF-1.
    Moschonas A; Kouraki M; Knox PG; Thymiakou E; Kardassis D; Eliopoulos AG
    Mol Cell Biol; 2008 Oct; 28(20):6208-22. PubMed ID: 18694960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma.
    Altenburg A; Baldus SE; Smola H; Pfister H; Hess S
    J Immunol; 1999 Apr; 162(7):4140-7. PubMed ID: 10201939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
    Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
    Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis.
    Mineva ND; Rothstein TL; Meyers JA; Lerner A; Sonenshein GE
    J Biol Chem; 2007 Jun; 282(24):17475-85. PubMed ID: 17446175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells.
    Sadeghlar F; Vogt A; Mohr RU; Mahn R; van Beekum K; Kornek M; Weismüller TJ; Branchi V; Matthaei H; Toma M; Schmidt-Wolf IGH; Kalff JC; Strassburg CP; González-Carmona MA
    Cancer Immunol Immunother; 2021 May; 70(5):1451-1464. PubMed ID: 33180184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells.
    Schwabe RF; Schnabl B; Kweon YO; Brenner DA
    J Immunol; 2001 Jun; 166(11):6812-9. PubMed ID: 11359840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40L induces matrix-metalloproteinase-9 but not tissue inhibitor of metalloproteinases-1 in cervical carcinoma cells: imbalance between NF-kappaB and STAT3 activation.
    Smola-Hess S; Schnitzler R; Hadaschik D; Smola H; Mauch C; Krieg T; Pfister H
    Exp Cell Res; 2001 Jul; 267(2):205-15. PubMed ID: 11426939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of SiHa cell to gemcitabine by CD40 activation and its overexpression in cervical carcinoma.
    Huang Q; Qu QX; Xie F; Hu JM; Chen YG; Zhang XG
    Med Oncol; 2011 Sep; 28(3):781-8. PubMed ID: 20467921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.